TABLE OF CONTENT 1 EXECUTIVE SUMMARY 1.1 MARKET ATTRACTIVENESS ANALYSIS 23 1.1.1 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 23 1.1.2 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 24 1.1.3 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 25 2 MARKET INTRODUCTION 2.1 DEFINITION 26 2.2 SCOPE OF THE STUDY 26 2.3 MARKET STRUCTURE 27 3 RESEARCH METHODOLOGY 3.1 RESEARCH PROCESS 28 3.2 PRIMARY RESEARCH 29 3.3 SECONDARY RESEARCH 30 3.4 MARKET SIZE ESTIMATION 30 3.5 FORECAST MODEL 32 3.6 LIST OF ASSUMPTIONS 33 4 MARKET INSIGHTS 5 MARKET DYNAMICS 5.1 INTRODUCTION 37 5.2 DRIVERS 39 5.2.1 INCREASING DEMAND FOR LOW-DOSAGE HYDRATE INHIBITORS IN THE OIL & GAS INDUSTRY 39 5.2.2 ADVANCEMENTS IN THE DRILLING OF GAS HYDRATES 39 5.2.3 DRIVERS IMPACT ANALYSIS 40 5.3 RESTRAINTS 40 5.3.1 ENVIRONMENTAL ISSUES ASSOCIATED WITH THE USE OF ANTI-AGGLOMERATE (AA) LDHI 40 5.3.2 RESTRAINTS IMPACT ANALYSIS 41 5.4 OPPORTUNITIES 41 5.4.1 INCREASING INVESTMENTS IN OIL & GAS EXPLORATION ACTIVITIES IN DEVELOPING ECONOMIES 41 5.4.2 RESEARCH & DEVELOPMENT OF ECO-FRIENDLY HYDRATE INHIBITORS 42 5.5 CHALLENGES 43 5.5.1 REQUIREMENT OF HIGH DOSAGE OF THERMODYNAMIC INHIBITORS 43 5.5.2 AVAILABILITY OF DEPRESSURIZATION METHOD FOR CONTROLLING HYDRATE FORMATION 43 5.6 TRENDS 43 5.6.1 SHIFT TOWARD RENEWABLE SOURCES OF ENERGY 43 6 MARKET FACTOR ANALYSIS 6.1 SUPPLY CHAIN ANALYSIS 44 6.1.1 RAW MATERIALS SUPPLIERS 45 6.1.2 HYDRATE INHIBITOR PRODUCERS 45 6.1.3 DISTRIBUTION CHANNEL 45 6.1.4 APPLICATIONS 46 6.2 PORTER’S FIVE FORCES MODEL 46 6.2.1 THREAT OF NEW ENTRANTS 47 6.2.2 INTENSITY OF COMPETITIVE RIVALRY 47 6.2.3 THREAT OF SUBSTITUTES 47 6.2.4 BARGAINING POWER OF SUPPLIERS 47 6.2.5 BARGAINING POWER OF BUYERS 48 6.3 PRICING ANALYSIS – BY REGION (USD/TON), 2018 48 6.4 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO 48 7 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE 7.1 INTRODUCTION 49 7.2 THERMODYNAMIC INHIBITORS (THI) 52 7.3 LOW-DOSAGE HYDRATE INHIBITORS (LDHI) 54 8 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION 8.1 INTRODUCTION 57 8.2 OFFSHORE OPERATIONS 60 8.3 ONSHORE OPERATIONS 62 9 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION 9.1 OVERVIEW 64 9.2 NORTH AMERICA 69 9.2.1 US 73 9.2.2 CANADA 76 9.3 EUROPE 79 9.3.1 RUSSIA 84 9.3.2 GERMANY 87 9.3.3 UK 90 9.3.4 NORWAY 93 9.3.5 NETHERLANDS 96 9.3.6 POLAND 99 9.3.7 ITALY 102 9.3.8 FRANCE 105 9.3.9 DENMARK 108 9.3.10 REST OF EUROPE 111 9.4 ASIA-PACIFIC 114 9.4.1 CHINA 118 9.4.2 JAPAN 121 9.4.3 INDIA 124 9.4.4 AUSTRALIA & NEW ZEALAND 127 9.4.5 INDONESIA 130 9.4.6 SOUTH KOREA 133 9.4.7 THAILAND 136 9.4.8 REST OF ASIA-PACIFIC 139 9.5 LATIN AMERICA 142 9.5.1 BRAZIL 146 9.5.2 MEXICO 149 9.5.3 ARGENTINA 152 9.5.4 REST OF LATIN AMERICA 155 9.6 THE MIDDLE EAST AND AFRICA 158 9.6.1 GCC 162 9.6.2 NIGERIA 165 9.6.3 IRAN 168 9.6.4 IRAQ 171 9.6.5 EGYPT 174 9.6.6 REST OF THE MIDDLE EAST AND AFRICA 177 10 COMPETITIVE LANDSCAPE 10.1 COMPETITIVE OVERVIEW 180 10.2 GLOBAL MARKET STRATEGY ANALYSIS 180 11 COMPANY PROFILES 11.1 SCHLUMBERGER 181 11.1.1 COMPANY OVERVIEW 181 11.1.2 FINANCIAL OVERVIEW 182 11.1.3 PRODUCT OFFERINGS 182 11.1.4 KEY DEVELOPMENTS 182 11.1.5 SWOT ANALYSIS 183 11.1.6 KEY STRATEGIES 183 11.2 BAKER HUGHES, A GE COMPANY LLC 184 11.2.1 COMPANY OVERVIEW 184 11.2.2 FINANCIAL OVERVIEW 184 11.2.3 PRODUCT OFFERINGS 185 11.2.4 KEY DEVELOPMENTS 185 11.2.5 SWOT ANALYSIS 185 11.2.6 KEY STRATEGIES 185 11.3 BASF SE 186 11.3.1 COMPANY OVERVIEW 186 11.3.2 FINANCIAL OVERVIEW 186 11.3.3 PRODUCT OFFERINGS 187 11.3.4 KEY DEVELOPMENTS 187 11.3.5 SWOT ANALYSIS 187 11.3.6 KEY STRATEGIES 187 11.4 HALLIBURTON 188 11.4.1 COMPANY OVERVIEW 188 11.4.2 FINANCIAL OVERVIEW 188 11.4.3 PRODUCT OFFERINGS 189 11.4.4 KEY DEVELOPMENTS 189 11.4.5 SWOT ANALYSIS 189 11.4.6 KEY STRATEGIES 189 11.5 HUNTSMAN INTERNATIONAL LLC 190 11.5.1 COMPANY OVERVIEW 190 11.5.2 FINANCIAL OVERVIEW 190 11.5.3 PRODUCT OFFERINGS 191 11.5.4 KEY DEVELOPMENTS 191 11.5.5 SWOT ANALYSIS 191 11.5.6 KEY STRATEGIES 191 11.6 ASHLAND 192 11.6.1 COMPANY OVERVIEW 192 11.6.2 FINANCIAL OVERVIEW 192 11.6.3 PRODUCT OFFERINGS 193 11.6.4 KEY DEVELOPMENTS 193 11.6.5 SWOT ANALYSIS 193 11.6.6 KEY STRATEGIES 193 11.7 ARKEMA 194 11.7.1 COMPANY OVERVIEW 194 11.7.2 FINANCIAL OVERVIEW 194 11.7.3 PRODUCT OFFERINGS 195 11.7.4 KEY DEVELOPMENTS 195 11.7.5 SWOT ANALYSIS 195 11.7.6 KEY STRATEGIES 195 11.8 EVONIK INDUSTRIES AG 196 11.8.1 COMPANY OVERVIEW 196 11.8.2 FINANCIAL OVERVIEW 196 11.8.3 PRODUCT OFFERINGS 197 11.8.4 KEY DEVELOPMENTS 197 11.8.5 SWOT ANALYSIS 197 11.8.6 KEY STRATEGIES 197 11.9 ECOLAB 198 11.9.1 COMPANY OVERVIEW 198 11.9.2 FINANCIAL OVERVIEW 198 11.9.3 PRODUCTS OFFERED 199 11.9.4 KEY DEVELOPMENTS 199 11.9.5 SWOT ANALYSIS 199 11.9.6 KEY STRATEGIES 199 11.10 FINORIC LLC 200 11.10.1 COMPANY OVERVIEW 200 11.10.2 FINANCIAL OVERVIEW 200 11.10.3 PRODUCTS OFFERED 200 11.10.4 KEY DEVELOPMENTS 200 11.10.5 SWOT ANALYSIS 201 11.10.6 KEY STRATEGIES 201 11.11 OMNI INDUSTRIAL SOLUTIONS 202 11.11.1 COMPANY OVERVIEW 202 11.11.2 FINANCIAL OVERVIEW 202 11.11.3 PRODUCTS OFFERED 202 11.11.4 KEY DEVELOPMENTS 202 11.11.5 SWOT ANALYSIS 203 11.11.6 KEY STRATEGIES 203   11.12 TETRA TECHNOLOGIES, INC. 204 11.12.1 COMPANY OVERVIEW 204 11.12.2 FINANCIAL OVERVIEW 204 11.12.3 PRODUCTS OFFERED 205 11.12.4 KEY DEVELOPMENTS 205 11.12.5 SWOT ANALYSIS 205 11.12.6 KEY STRATEGIES 205 12 APPENDIX 12.1 REFERENCES 206 12.2 RELATED REPORTS 206

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS 32 TABLE 2 MANUFACTURERS MARKET CONCENTRATION RATIO, BY REGION 47 TABLE 3 GLOBAL HYDRATE INHIBITORS, BY TYPE, 2017–2025 (USD THOUSAND) 49 TABLE 4 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 50 TABLE 5 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 51 TABLE 6 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 51 TABLE 7 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2017–2025 (USD THOUSAND) 52 TABLE 8 GLOBAL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY REGION, 2017–2025 (TONS) 52 TABLE 9 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 53 TABLE 10 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 54 TABLE 11 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2017–2025 (USD THOUSAND) 54 TABLE 12 GLOBAL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY REGION, 2017–2025 (TONS) 55 TABLE 13 GLOBAL HYDRATE INHIBITORS, BY APPLICATION, 2017–2025 (USD THOUSAND) 57 TABLE 14 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 58 TABLE 15 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2017–2025 (USD THOUSAND) 59 TABLE 16 GLOBAL HYDRATE INHIBITORS MARKET FOR OFFSHORE OPERATIONS, BY REGION, 2017–2025 (TONS) 60 TABLE 17 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2017–2025 (USD THOUSAND) 61 TABLE 18 GLOBAL HYDRATE INHIBITORS MARKET FOR ONSHORE OPERATIONS, BY REGION, 2017–2025 (TONS) 62 TABLE 19 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2017–2025 (USD THOUSAND) 64 TABLE 20 GLOBAL HYDRATE INHIBITORS MARKET, BY REGION, 2017–2025 (TONS) 65 TABLE 21 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 66 TABLE 22 GLOBAL HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 66 TABLE 23 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 66 TABLE 24 GLOBAL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 67 TABLE 25 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (USD THOUSAND) 68 TABLE 26 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (TONS) 68 TABLE 27 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 68 TABLE 28 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 69 TABLE 29 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 69 TABLE 30 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 69 TABLE 31 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 70 TABLE 32 NORTH AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 70 TABLE 33 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 71 TABLE 34 NORTH AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 71 TABLE 35 US HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 72 TABLE 36 US HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 72 TABLE 37 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 72 TABLE 38 US HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 73 TABLE 39 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 73 TABLE 40 US HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 74 TABLE 41 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 74 TABLE 42 US HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 74 TABLE 43 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 75 TABLE 44 CANADA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 75 TABLE 45 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 75 TABLE 46 CANADA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 76 TABLE 47 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 76 TABLE 48 CANADA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 77 TABLE 49 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 77 TABLE 50 CANADA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 77 TABLE 51 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (USD THOUSAND) 78 TABLE 52 EUROPE HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (TONS) 79 TABLE 53 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 79 TABLE 54 EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 80 TABLE 55 EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 80 TABLE 56 EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 80 TABLE 57 EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 81 TABLE 58 EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 81 TABLE 59 EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 82 TABLE 60 EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 82 TABLE 61 RUSSIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 83 TABLE 62 RUSSIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 83 TABLE 63 RUSSIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 83 TABLE 64 RUSSIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 84 TABLE 65 RUSSIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 84 TABLE 66 RUSSIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 85 TABLE 67 RUSSIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 85 TABLE 68 RUSSIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 85 TABLE 69 GERMANY HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 86 TABLE 70 GERMANY HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 86 TABLE 71 GERMANY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 86 TABLE 72 GERMANY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 87 TABLE 73 GERMANY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 87 TABLE 74 GERMANY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 88 TABLE 75 GERMANY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 88 TABLE 76 GERMANY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 88 TABLE 77 UK HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 89 TABLE 78 UK HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 89 TABLE 79 UK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 89 TABLE 80 UK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 90 TABLE 81 UK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 90 TABLE 82 UK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 91 TABLE 83 UK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 91 TABLE 84 UK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 91 TABLE 85 NORWAY HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 92 TABLE 86 NORWAY HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 92 TABLE 87 NORWAY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 92 TABLE 88 NORWAY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 93 TABLE 89 NORWAY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 93 TABLE 90 NORWAY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 94 TABLE 91 NORWAY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 94 TABLE 92 NORWAY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 94 TABLE 93 NETHERLANDS HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 95 TABLE 94 NETHERLANDS HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 95 TABLE 95 NETHERLANDS HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 95 TABLE 96 NETHERLANDS HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 96 TABLE 97 NETHERLANDS HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 96 TABLE 98 NETHERLANDS HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 97 TABLE 99 NETHERLANDS HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 97 TABLE 100 NETHERLANDS HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 97 TABLE 101 POLAND HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 98 TABLE 102 POLAND HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 98 TABLE 103 POLAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 98 TABLE 104 POLAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 99 TABLE 105 POLAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 99 TABLE 106 POLAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 100 TABLE 107 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 100 TABLE 108 POLAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 100 TABLE 109 ITALY HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 101 TABLE 110 ITALY HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 101 TABLE 111 ITALY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 101 TABLE 112 ITALY HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 102 TABLE 113 ITALY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 102 TABLE 114 ITALY HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 103 TABLE 115 ITALY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 103 TABLE 116 ITALY HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 103 TABLE 117 FRANCE HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 104 TABLE 118 FRANCE HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 104 TABLE 119 FRANCE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 104 TABLE 120 FRANCE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 105 TABLE 121 FRANCE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 105 TABLE 122 FRANCE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 106 TABLE 123 FRANCE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 106 TABLE 124 FRANCE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 106 TABLE 125 DENMARK HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 107 TABLE 126 DENMARK HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 107 TABLE 127 DENMARK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 107 TABLE 128 DENMARK HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 108 TABLE 129 DENMARK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 108 TABLE 130 DENMARK HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 109 TABLE 131 DENMARK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 109 TABLE 132 DENMARK HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 109 TABLE 133 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 110 TABLE 134 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 110 TABLE 135 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 110 TABLE 136 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 111 TABLE 137 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 111 TABLE 138 REST OF EUROPE HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 112 TABLE 139 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 112 TABLE 140 REST OF EUROPE HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 112 TABLE 141 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (USD THOUSAND) 113 TABLE 142 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (TONS) 113 TABLE 143 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 114 TABLE 144 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 114 TABLE 145 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 114 TABLE 146 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 115 TABLE 147 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 115 TABLE 148 ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 116 TABLE 149 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 116 TABLE 150 ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 116 TABLE 151 CHINA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 117 TABLE 152 CHINA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 117 TABLE 153 CHINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 117 TABLE 154 CHINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 118 TABLE 155 CHINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 118 TABLE 156 CHINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 119 TABLE 157 CHINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 119 TABLE 158 CHINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 119 TABLE 159 JAPAN HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 120 TABLE 160 JAPAN HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 120 TABLE 161 JAPAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 120 TABLE 162 JAPAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 121 TABLE 163 JAPAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 121 TABLE 164 JAPAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 122 TABLE 165 JAPAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 122 TABLE 166 JAPAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 122 TABLE 167 INDIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 123 TABLE 168 INDIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 123 TABLE 169 INDIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 123 TABLE 170 INDIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 124 TABLE 171 INDIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 124 TABLE 172 INDIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 125 TABLE 173 INDIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 125 TABLE 174 INDIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 125 TABLE 175 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 126 TABLE 176 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 126 TABLE 177 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 126 TABLE 178 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 127 TABLE 179 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 127 TABLE 180 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 128 TABLE 181 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 128 TABLE 182 AUSTRALIA & NEW ZEALAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 128 TABLE 183 INDONESIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 129 TABLE 184 INDONESIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 129 TABLE 185 INDONESIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 129 TABLE 186 INDONESIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 130 TABLE 187 INDONESIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 130 TABLE 188 INDONESIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 131 TABLE 189 INDONESIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 131 TABLE 190 INDONESIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 131 TABLE 191 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 132 TABLE 192 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 132 TABLE 193 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 132 TABLE 194 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 133 TABLE 195 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 133 TABLE 196 SOUTH KOREA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 134 TABLE 197 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 134 TABLE 198 SOUTH KOREA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 134 TABLE 199 THAILAND HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 135 TABLE 200 THAILAND HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 135 TABLE 201 THAILAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 135 TABLE 202 THAILAND HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 136 TABLE 203 THAILAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 136 TABLE 204 THAILAND HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 137 TABLE 205 THAILAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 137 TABLE 206 THAILAND HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 137 TABLE 207 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 138 TABLE 208 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 138 TABLE 209 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 138 TABLE 210 REST OF HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 139 TABLE 211 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 139 TABLE 212 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 140 TABLE 213 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 140 TABLE 214 REST OF ASIA-PACIFIC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 140 TABLE 215 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (USD THOUSAND) 141 TABLE 216 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (TONS) 141 TABLE 217 LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 142 TABLE 218 LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 142 TABLE 219 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 142 TABLE 220 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 143 TABLE 221 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 143 TABLE 222 LATIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 144 TABLE 223 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 144 TABLE 224 LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 144 TABLE 225 BRAZIL HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 145 TABLE 226 BRAZIL HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 145 TABLE 227 BRAZIL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 145 TABLE 228 BRAZIL HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 146 TABLE 229 BRAZIL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 146 TABLE 230 BRAZIL HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 147 TABLE 231 BRAZIL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 147 TABLE 232 BRAZIL HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 147 TABLE 233 MEXICO HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 148 TABLE 234 MEXICO HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 148 TABLE 235 MEXICO HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 148 TABLE 236 MEXICO HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 149 TABLE 237 MEXICO HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 149 TABLE 238 MEXICO HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 150 TABLE 239 MEXICO HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 150 TABLE 240 MEXICO HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 150 TABLE 241 ARGENTINA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 151 TABLE 242 ARGENTINA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 151 TABLE 243 ARGENTINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 151 TABLE 244 ARGENTINA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 152 TABLE 245 ARGENTINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 152 TABLE 246 ARGENTINA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 153 TABLE 247 ARGENTINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 153 TABLE 248 ARGENTINA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 153 TABLE 249 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 154 TABLE 250 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 154 TABLE 251 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 154 TABLE 252 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 155 TABLE 253 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 155 TABLE 254 REST OF LATHIN AMERICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 156 TABLE 255 REST OF LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 156 TABLE 256 REST OF LATIN AMERICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 156 TABLE 257 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (USD THOUSAND) 157 TABLE 258 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY COUNTRY, 2017–2025 (TONS) 157 TABLE 259 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 158 TABLE 260 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 158 TABLE 261 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 158 TABLE 262 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 159 TABLE 263 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 159 TABLE 264 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 160 TABLE 265 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 160 TABLE 266 THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 160 TABLE 267 GCC HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 161 TABLE 268 GCC HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 161 TABLE 269 GCC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 161 TABLE 270 GCC HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 162 TABLE 271 GCC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 162 TABLE 272 GCC HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 163 TABLE 273 GCC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 163 TABLE 274 GCC HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 163 TABLE 275 NIGERIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 164 TABLE 276 NIGERIA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 164 TABLE 277 NIGERIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 164 TABLE 278 NIGERIA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 165 TABLE 279 NIGERIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 165 TABLE 280 NIGERIA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 166 TABLE 281 NIGERIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 166 TABLE 282 NIGERIA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 166 TABLE 283 IRAN HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 167 TABLE 284 IRAN HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 167 TABLE 285 IRAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 167 TABLE 286 IRAN HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 168 TABLE 287 IRAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 168 TABLE 288 IRAN HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 169 TABLE 289 IRAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 169 TABLE 290 IRAN HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 169 TABLE 291 IRAQ HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 170 TABLE 292 IRAQ HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 170 TABLE 293 IRAQ HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 170 TABLE 294 IRAQ HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 171 TABLE 295 IRAQ HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 171 TABLE 296 IRAQ HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 172 TABLE 297 IRAQ HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 172 TABLE 298 IRAQ HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 172 TABLE 299 EGYPT HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 173 TABLE 300 EGYPT HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 173 TABLE 301 EGYPT HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 173 TABLE 302 EGYPT HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 174 TABLE 303 EGYPT HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 174 TABLE 304 EGYPT HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 175 TABLE 305 EGYPT HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 175 TABLE 306 EGYPT HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 175 TABLE 307 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (USD THOUSAND) 176 TABLE 308 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY TYPE, 2017–2025 (TONS) 176 TABLE 309 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (USD THOUSAND) 176 TABLE 310 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR THERMODYNAMIC INHIBITORS (THI), BY TYPE, 2017–2025 (TONS) 177 TABLE 311 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (USD THOUSAND) 177 TABLE 312 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET FOR LOW-DOSAGE HYDRATE INHIBITORS (LDHI), BY TYPE, 2017–2025 (TONS) 178 TABLE 313 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (USD THOUSAND) 178 TABLE 314 REST OF THE MIDDLE EAST AND AFRICA HYDRATE INHIBITORS MARKET, BY APPLICATION, 2017–2025 (TONS) 178 TABLE 315 SCHLUMBERGER: PRODUCT OFFERINGS 181 TABLE 316 BAKER HUGHES, A GE COMPANY LLC: PRODUCT OFFERINGS 184 TABLE 317 BASF SE: PRODUCT OFFERINGS 186 TABLE 318 HALLIBURTON: PRODUCT OFFERINGS 188 TABLE 319 HUNTSMAN INTERNATIONAL LLC: PRODUCT OFFERINGS 190 TABLE 320 ASHLAND: PRODUCT OFFERINGS 192 TABLE 321 PRODUCT OFFERINGS 194 TABLE 322 EVONIK INDUSTRIES AG: PRODUCT OFFERINGS 196 TABLE 323 ECOLAB: PRODUCTS OFFERED 198 TABLE 324 FINORIC LLC: PRODUCTS OFFERED 199 TABLE 325 OMNI INDUSTRIAL SOLUTIONS: PRODUCTS OFFERED 201 TABLE 326 TETRA TECHNOLOGIES, INC: PRODUCTS OFFERED 204 LIST OF FIGURES FIGURE 1 MARKET SYNOPSIS 22 FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL HYDRATE INHIBITORS MARKET 23 FIGURE 3 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY TYPE 23 FIGURE 4 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY APPLICATION 24 FIGURE 5 GLOBAL HYDRATE INHIBITORS MARKET ANALYSIS, BY REGION 25 FIGURE 6 GLOBAL HYDRATE INHIBITORS MARKET: STRUCTURE 27 FIGURE 7 RESEARCH PROCESS 28 FIGURE 8 TOP-DOWN & BOTTOM-UP APPROACHES 31 FIGURE 9 NORTH AMERICA MARKET SHARE BY COUNTRY (2018 VS 2025) 34 FIGURE 10 EUROPE MARKET SHARE BY COUNTRY (2018 VS 2025) 34 FIGURE 11 ASIA-PACIFIC MARKET SHARE B

Global Hydrate Inhibitors Market are Schlumberger Limited (US), Baker Hughes, a GE Company LLC (US), BASF SE (Germany), Halliburton (US), Ecolab (US), Huntsman International LLC (US), Ashland (US), ARKEMA (France), Evonik Industries AG (Germany), Finoric LLC (US), Omni industrial solutions (US), and Tetra Technologies, Inc. (the US)